New T cell therapies succeed with a narrow band of cancers. Can they be made to work for the rest of them, too?
Experts reflect on the state of eldercare and questions of genomic privacy.
Genetic tests and genome sequencing are generating terabytes of sensitive private data. How can they be kept safe?
New studies aim to determine what consumers do—or don’t do—after they’ve had a mail-order genome test.
There’s remarkable science behind mail-order gene tests. But should buyers beware?
No Articles Found.